Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes

Journal of Urology

Volumn 185, Issue 5, 2011, Pages 1828-1834

  Wessells, Hunter ^a,g   Penson, David F ^b   Cleary, Patricia ^c   Rutledge, Brandy N ^c   Lachin, John M ^c   McVary, Kevin T ^d   Schade, David S ^e   Sarma, Aruna V ^f  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

Author keywords

blood glucose; diabetes mellitus; erectile dysfunction; risk

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGE DISTRIBUTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; ERECTILE DYSFUNCTION; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PERIPHERAL NEUROPATHY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; URINARY TRACT DISEASE;

ADULT; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 1; ERECTILE DYSFUNCTION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LOGISTIC MODELS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 79953776323     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.12.098     Document Type: Article

References (30)

1. C.S. Saigal, H. Wessells, and J. Pace Predictors and prevalence of erectile dysfunction in a racially diverse population Arch Intern Med 166 2006 207
2. G. De Berardis, M. Franciosi, and M. Belfiglio Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked Diabetes Care 25 2002 284
3. R.A. Costabile Optimizing treatment for diabetes mellitus induced erectile dysfunction J Urol 170 2003 S35
4. V. Fonseca, A. Seftel, and J. Denne Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials Diabetologia 47 2004 1914
5. J.S. Brown, H. Wessells, and M.B. Chancellor Urologic complications of diabetes Diabetes Care 28 2005 177
6. K. Chitaley Type 1 and type 2 diabetic-erectile dysfunction: same diagnosis (ICD-9), different disease? J Sex Med 6 2009 262
7. O. Kalter-Leibovici, J. Wainstein, and A. Ziv Clinical, socioeconomic, and lifestyle parameters associated with erectile dysfunction among diabetic men Diabetes Care 28 2005 1739
8. R. Klein, B.E. Klein, and S.E. Moss Ten-year incidence of self-reported erectile dysfunction in people with long-term type 1 diabetes J Diabetes Complications 19 2005 35
9. D.K. McCulloch, I.W. Campbell, and F.C. Wu The prevalence of diabetic impotence Diabetologia 18 1980 279
10. J.H. Romeo, A.D. Seftel, and Z.T. Madhun Sexual function in men with diabetes type 2: association with glycemic control J Urol 163 2000 788
11. S.A. Khatana, T.H. Taveira, and M.M. Miner Does cardiovascular risk reduction alleviate erectile dysfunction in men with type II diabetes mellitus? Int J Impot Res 20 2008 501
12. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group D.M. Nathan, and B. Zinman Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (19832005) Arch Intern Med 169 2009 1307
13. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus The Diabetes Control and Complications Trial Research Group N Engl J Med 329 1993 977
14. Epidemiology of Diabetes Interventions and Complications (EDIC) Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort Diabetes Care 22 1999 99
15. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus JAMA 287 2002 2563
16. D.M. Nathan, P.A. Cleary, and J.Y. Backlund Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N Engl J Med 353 2005 2643
17. R.C. Rosen, A. Riley, and G. Wagner The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction Urology 49 1997 822
18. E.L. Feldman, M.J. Stevens, and P.K. Thomas A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy Diabetes Care 17 1994 1281
19. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics ETDRS report number 7 Ophthalmology 98 1991 741
20. D.M. Nathan, J. Lachin, and P. Cleary Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus N Engl J Med 348 2003 2294
21. P.A. Cleary, T.J. Orchard, and S. Genuth The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Diabetes 55 2006 3556
22. M.J. Barry, F.J. Fowler Jr, and M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia The Measurement Committee of the American Urological Association J Urol 148 1992 1549
23. M. Brownlee Negative consequences of glycation Metabolism 49 2000 9
24. J.J. Cartledge, I. Eardley, and J.F. Morrison Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes BJU Int 87 2001 402
25. B. Musicki, M.F. Kramer, and R.E. Becker Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction Proc Natl Acad Sci U S A 102 2005 11870
26. A.D. Seftel, N.D. Vaziri, and Z. Ni Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS Urology 50 1997 1016
27. C.G. Bacon, M.A. Mittleman, and I. Kawachi Sexual function in men older than 50 years of age: results from the health professionals follow-up study Ann Intern Med 139 2003 161
28. R. Tomar, S. Dhindsa, and A. Chaudhuri Contrasting testosterone concentrations in type 1 and type 2 diabetes Diabetes Care 29 2006 1120
29. V. Kupelian, R. Shabsigh, and T.G. Travison Is there a relationship between sex hormones and erectile dysfunction? Results from the Massachusetts Male Aging Study J Urol 176 2006 2584
30. T.G. Travison, R. Shabsigh, and A.B. Araujo The natural progression and remission of erectile dysfunction: results from the Massachusetts Male Aging Study J Urol 177 2007 241